Dedifferentiated Ovarian Carcinoma with ARID1A and ARID1B Mutations: A Clinicopathological Report and Literature Review
International Journal of Surgical Pathology · 2023
DOI: 10.1177/10668969231157776 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Surgical Pathology, 2023. Verfasst von Maria Kamal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Ovarian Neoplasms, Carcinoma, Endometrioid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Dedifferentiated carcinoma of the female genital tract is a relatively recently recognized aggressive tumor affecting predominantly perimenopausal and postmenopausal women. In addition to having an undifferentiated component, dedifferentiated carcinoma includes a juxtaposed endometrioid adenocarcinoma, FIGO grade 1 or 2. Molecular characterization of these tumors has been a subject of discussion in multiple recent articles. We present a case of dedifferentiated carcinoma of the ovary in a 70-year-old female demonstrating concurrent inactivation of ARID1A and ARID1B . To the best of our knowledge, this is the second clinical report demonstrating dedifferentiated carcinoma of the ovary with concurrent inactivation of ARID1A and ARID1B . ARID1A and ARID1B inactivation seems to represent an alternate mechanism of switch/sucrose nonfermentable complex inactivation in the development of dedifferentiated carcinoma. Additional studies are warranted to precisely understand the molecular mechanism of cellular dedifferentiation in the dedifferentiated endometrial/ovarian carcinomas, thus guiding the development of targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
- Genetics Lab, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
ORCID-Profile: Maria Kamal, Doaa Atwi
Zitieren
APA
Kamal, M., Atwi, D., Pang, H., Li, S., & Hassell, L. (2023). Dedifferentiated Ovarian Carcinoma with ARID1A and ARID1B Mutations: A Clinicopathological Report and Literature Review. International Journal of Surgical Pathology. https://doi.org/10.1177/10668969231157776
Vancouver
Kamal M, Atwi D, Pang H, Li S, Hassell L. Dedifferentiated Ovarian Carcinoma with ARID1A and ARID1B Mutations: A Clinicopathological Report and Literature Review. International Journal of Surgical Pathology. 2023. doi:10.1177/10668969231157776
BibTeX
@article{Kamal2023,
author = {Kamal, Maria and Atwi, Doaa and Pang, Hui and Li, Shibo and Hassell, Lewis},
title = {Dedifferentiated Ovarian Carcinoma with ARID1A and ARID1B Mutations: A Clinicopathological Report and Literature Review},
journal = {International Journal of Surgical Pathology},
year = {2023},
doi = {10.1177/10668969231157776}
}
EUVIMED